Acute localized exanthematous pustulosis caused by enoxaparin

N Mozafari; M Farjami; E Jamali; H Rostami; Y Ketabi

doi:10.1111/ced.14805

Acute localized exanthematous pustulosis caused by enoxaparin

Clin Exp Dermatol. 2021 Dec;46(8):1607-1609. doi: 10.1111/ced.14805. Epub 2021 Sep 2.

Authors

N Mozafari^{1

2}, M Farjami³, E Jamali⁴, H Rostami², Y Ketabi¹

Affiliations

¹ Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Departments of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁴ Department of Pathology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 34192360
DOI: 10.1111/ced.14805

Abstract

Notably, enoxaparin has not been described to cause acute localized exanthematous pustulosis (ALEP). Herein, we present a case of a woman with a cutaneous drug reaction consistent with ALEP that occurred after enoxaparin. This case highlights enoxaprin as a novel causative agent for this type of drug reaction.

Publication types

Case Reports
Letter

MeSH terms

Acute Generalized Exanthematous Pustulosis / etiology*
Acute Generalized Exanthematous Pustulosis / pathology
Adult
Anticoagulants / administration & dosage
Anticoagulants / adverse effects*
Enoxaparin / administration & dosage
Enoxaparin / adverse effects*
Female
Humans
Injections, Intradermal
Venous Thrombosis / prevention & control
Withholding Treatment

Substances

Anticoagulants
Enoxaparin